Risklick is a promising startup founded in 2019 with a vision to revolutionize the development of clinical trial protocols using AI. Their slogan "Develop the Clinical Trial Protocols of the Future Using AI" reflects their dedication to leveraging cutting-edge technology for medical innovation. The innovative AI software, Protocol AI, aims to empower experts in conducting faster, cheaper, and safer trials, potentially shaping the future of medical research and development.
General Information
Get notified when Risklick moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Risklick
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Switzerland Market
About Risklick
Taxonomy: Clinical Trials, AI Software, Protocol Development, Medical Innovation, Risk Assessment, Data-Driven Tool, Experimental Treatment, Safety Assessment, Trial Cost Reduction, Protocol Design, Medical Research, Risk Analysis, Innovation in Healthcare
No funding data available for Risklick yet.
Get notified when Risklick raises fundingLatest News
View AllRisklick Alternatives & Competitors
Market and Liquidity Risk Management and Portfolio Simulation Tooling for Digital Assets and DeFi.
Empowering direct user connections and developer innovation within the Farcaster protocol.
FAQ About Risklick
Don't just browse. Track.
Signal Tracker monitors Risklick and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.